首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1746861

日本再生醫學市場報告（按類型、應用、最終用戶和地區）2025-2033

Japan Regenerative Medicine Market Report by Type, Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本再生醫學市場規模達85億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到221億美元，2025-2033年期間的複合年成長率（CAGR）為11.23%。市場發展受到一系列因素的驅動，包括對移植排斥反應的擔憂加劇、對再生骨科治療的需求增加、對牙齒再生的日益關注以及藥物在傷口癒合中的應用日益增多。

再生醫學是生物醫學領域中一個蓬勃發展的領域，專注於修復受損的組織和器官。它利用實驗室培養的幹細胞，將其安全地移植到體內，以促進骨骼、軟骨、血管和重要器官等各種身體部位的再生。這種綜合方法涵蓋各種細胞和非細胞再生療法，並融合了免疫調節和組織工程等技術。除了在組織修復中的作用外，再生醫學在治療阿茲海默症、帕金森氏症、心血管疾病 (CVD)、骨質疏鬆症和脊髓損傷等頑固性疾病方面也展現出巨大的潛力。隨著研究的進展，再生醫學展現出革命性療法的樂觀前景，這些療法有望顯著提升患者的生活品質和整體醫療保健效果。

日本再生醫學市場趨勢：

日本再生醫學市場正經歷大幅成長，這主要得益於老齡人口的成長。這種人口結構的變化與糖尿病、心臟病和骨關節炎等慢性疾病發病率的上升有關，從而顯著促進了市場的擴張。此外，人們對幹細胞療法和基因工程研究的日益關注，也促進了再生醫學領域的創新。幹細胞和其他細胞療法在組織再生和修復方面的應用日益廣泛，進一步刺激了市場的發展。值得注意的是，市場積極的發展軌跡得益於用於再生醫學研發進步的資金和監管支持。生物技術的不斷進步促進了更精準、更有效的再生療法的開發，從而推動了市場的成長。此外，患者對再生治療方案可用性的認知不斷提高，這也成為市場擴張的另一個催化劑。癌症發生率的不斷上升以及對更有效、更適合患者的治療方法的追求，推動了癌症治療對再生醫學的需求，在市場成長中發揮了重要作用。

日本再生醫學市場細分：

類型洞察：

幹細胞療法
生物材料
組織工程
其他

應用程式洞察：

骨移植替代品
骨關節疾病
皮膚科
心血管
中樞神經系統
其他

最終用戶洞察：

醫院
專科診所
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本再生醫學市場迄今表現如何？未來幾年將如何表現？
COVID-19對日本再生醫學市場有何影響？
日本再生醫療市場按類型分類是怎樣的？
日本再生醫療市場按應用分類的狀況如何？
根據最終用戶，日本再生醫學市場是如何分類的？
日本再生醫學市場的價值鏈分為哪些階段？
日本再生醫學的關鍵促進因素和挑戰是什麼？
日本再生醫學市場的結構是怎麼樣的？主要參與者是誰？
日本再生醫療市場的競爭程度如何？

本報告回答的關鍵問題：

日本再生醫學市場迄今表現如何？未來幾年將如何表現？
COVID-19對日本再生醫學市場有何影響？
日本再生醫療市場按類型分類是怎樣的？
日本再生醫療市場按應用分類的狀況如何？
根據最終用戶，日本再生醫學市場是如何分類的？
日本再生醫學市場的價值鏈分為哪些階段？
日本再生醫學的關鍵促進因素和挑戰是什麼？
日本再生醫學市場的結構是怎麼樣的？主要參與者是誰？
日本再生醫療市場的競爭程度如何？

Japan regenerative medicine market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.1 Billion by 2033, exhibiting a growth rate (CAGR) of 11.23% during 2025-2033. The market is being driven by a range of factors, including heightened worries about transplant rejection, a greater need for regenerative orthopedic treatments, an increasing focus on dental regeneration, and the growing utilization of medicine for wound healing.

Regenerative medicine is an auspicious field within biomedical science that focuses on repairing damaged tissues and organs. It involves the use of laboratory-cultivated stem cells, which are safely transplanted into the body to encourage the regeneration of various bodily components such as bones, cartilage, blood vessels, and essential organs. This comprehensive approach includes a variety of regenerative therapies, both cellular and acellular, incorporating techniques like immunomodulation and tissue engineering. Apart from its role in tissue repair, regenerative medicine shows great promise in addressing persistent conditions such as Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research progresses, it presents an optimistic outlook for revolutionary treatments that have the potential to significantly enhance patients' quality of life and overall healthcare outcomes.

Japan Regenerative Medicine Market Trends:

The Japan regenerative medicine market is experiencing substantial growth primarily due to the expanding elderly population. This demographic shift correlates with a heightened incidence of chronic ailments like diabetes, heart disease, and osteoarthritis, thus significantly contributing to the market's expansion. Moreover, the increasing focus on stem cell therapies and genetic engineering research is fostering innovation within the realm of regenerative medicine. The market is further stimulated by the growing utilization of stem cells and other cell-based therapies for the purpose of tissue regeneration and repair. Notably, the positive trajectory of the market is sustained by the allocation of funding and regulatory support for the advancement of regenerative medicine research and development. The continual advancements in biotechnology are facilitating the development of more precise and efficacious regenerative therapies, thereby bolstering the market's growth. Additionally, the rising awareness among patients regarding the availability of regenerative treatment options is serving as an additional catalyst for market expansion. The increasing occurrence of cancer and the quest for treatments that are both more efficient and accommodating for patients are driving the need for regenerative medicine in cancer treatment, playing a substantial role in the growth of the market.

Japan Regenerative Medicine Market Segmentation:

Type Insights:

Stem Cell Therapy
Biomaterial
Tissue Engineering
Others

Application Insights:

Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others

End User Insights:

Hospitals
Specialty Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan regenerative medicine market?
What is the breakup of the Japan regenerative medicine market on the basis of type?
What is the breakup of the Japan regenerative medicine market on the basis of application?
What is the breakup of the Japan regenerative medicine market on the basis of end user?
What are the various stages in the value chain of the Japan regenerative medicine market?
What are the key driving factors and challenges in the Japan regenerative medicine?
What is the structure of the Japan regenerative medicine market and who are the key players?
What is the degree of competition in the Japan regenerative medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Regenerative Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Regenerative Medicine Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Regenerative Medicine Market - Breakup by Type

6.1 Stem Cell Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Biomaterial
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Tissue Engineering
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Others
- 6.4.1 Historical and Current Market Trends (2019-2024)
- 6.4.2 Market Forecast (2025-2033)

7 Japan Regenerative Medicine Market - Breakup by Application

7.1 Bone Graft Substitutes
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Osteoarticular Diseases
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Dermatology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Cardiovascular
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Central Nervous System
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Regenerative Medicine Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Specialty Clinics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2019-2024)
- 8.3.2 Market Forecast (2025-2033)

9 Japan Regenerative Medicine Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Regenerative Medicine Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis